AC Immune (ACIU) Leases (2016 - 2026)
AC Immune (ACIU) reported Leases of $5.5 billion for Q1 2026, up 95318.95% year-over-year from N/an in Q1 2025, and down 3.11% quarter-over-quarter from $5.7 billion in Q4 2025.
AC Immune (ACIU) Leases (2016 - 2026) Analysis & Trends
AC Immune (ACIU) has 10 years of Leases data on file, last reported at $5.5 billion in Q1 2026.
- Leases for Q1 2026 came in at $5.5 billion, up 95318.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 95318.95% YoY), and the FY2025 annual result was $5.5 billion, up 88127.89% from the prior year.
- Leases fell to $5.5 billion in Q1 2026 per ACIU's latest filing, from $5.7 billion in the prior quarter.
- Over five years, Leases peaked at $5.7 billion in Q4 2025 and troughed at $2.6 million in Q3 2022.
- A 5-year average of $893.7 million and a median of $3.6 million in 2024 frame the typical range for Leases.
- The sharpest annual moves came in 2022 and 2023: Leases tumbled 99.91% in 2022, then surged 135580.19% in 2023.
- A 5-year view of Leases shows it stood at $2.9 million in 2022, then surged by 135580.19% to $4.0 billion in 2023, then tumbled by 99.84% to $6.2 million in 2024, then soared by 91422.64% to $5.7 billion in 2025, then dropped by 3.11% to $5.5 billion in 2026.
- Business Quant data shows ACIU's Leases at $5.5 billion in Q1 2026, $5.7 billion in Q4 2025, and $5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 61,822.50 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,048.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 285.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.69 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | AC Immune | 1.35 Bn | -94.16 Bn | - | 5.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.50 Bn |
| Dec 31, 2025 | 5.68 Bn |
| Sep 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 3.95 Bn |
| Sep 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 3.16 Bn |
| Sep 30, 2021 | 2.80 Bn |
| Jun 30, 2021 | 2.96 Bn |